The recommendation was nothing new, since this has been the shared consensus within both government and academic circles ever since the Legislative Yuan passed the Act for the Development of Biotech and New Pharmaceuticals Industry in June 2007. The Committee's recommendation nevertheless did serve to signal the government's continued commitment to this course of action.
誠然，這項建議並無新意，早自 2007 年 6 月立法院通過《生技新藥產業發展條例》後，政府與學界就已定調，將「新藥研發」列為台灣未來生技產業的發展主軸，然而此次會議仍再次確認並宣誓了新政府的決心。